Low‐Dose Versus High‐Dose Drug‐Coated Balloon After Jetstream Atherectomy for Severely Calcified Femoropopliteal Lesions: The JUPITER Multicenter Study
Year: 2026
Type: article
Study design: Observational Study
Abstract: BACKGROUND: Second-generation low-dose drug-coated balloons (LD-DCBs) have shown clinical efficacy comparable to high-dose DCBs (HD-DCBs) for femoropopliteal artery (FPA) lesions. Whether paclitaxel dose density remains clinically relevant after aggressive vessel preparation with atherectomy in severely calcified FPA lesions remains uncertain. This study aimed to compare 1-year clinical outcomes of second-generation LD-DCB and HD-DCB following Jetstream atherectomy in patients with severely calcified FPA lesions. AIMS: This study aimed to compare 1-year clinical outcomes of second-generation LD-DCB and HD-DCB following Jetstream atherectomy in patients with severely calcified FPA lesions. METHODS: This multicenter retrospective study included 262 patients with severely calcified FPA lesions who underwent endovascular therapy with Jetstream atherectomy followed by second-generation LD-DCB (n = 175) or HD-DCB (n = 87). Propensity-score matching yielded 79 well-balanced pairs. The primary outcome was 1-year primary patency; secondary outcomes included freedom from clinically driven target-lesion revascularization (TLR), limb salvage, and overall survival. RESULTS: In the overall cohort before matching, 1-year primary patency was similar between second-generation LD-DCB and HD-DCB (86.8% vs. 83.1%, log-rank p = 0.578), with comparable freedom from TLR, limb salvage, and overall survival. After propensity score matching, primary patency remained similar between groups (88.5% vs. 84.9%, log-rank p = 0.588), as did freedom from TLR, limb salvage, and overall survival. Findings were consistent across calcification-related subgroups. In an exploratory Cox analysis, second-generation LD-DCB was not associated with an increased risk of restenosis compared with HD-DCB. CONCLUSIONS: After Jetstream atherectomy for severely calcified FPA lesions, second-generation LD-DCB and HD-DCB were associated with comparable 1-year clinical outcomes, suggesting that either strategy may be a reasonable treatment option.
DOI: 10.1002/ccd.71018
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Open Access status: bronze
OpenAlex ID: W7226028817
